NASDAQ:LOGC Shareholder Notice: Investigation over Possible Securities Laws Violations by LogicBio Therapeutics, Inc.
An investigation for investors in LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares over potential securities laws violations by LogicBio Therapeutics, Inc. was announced.
View full press release